Coronary Thrombosis: Pathogenesis and Prevention

  • G. V. R. Born
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 281)


Acute myocardial infarction is most commonly initiated by fissuring of an atheromatous plaque. Through such fissures the blood is exposed to thrombogenic constituents of the intima, causing thrombotic obstruction of the coronary artery. Why plaque fissuring occurs is not known. Our investigation is to establish which types of plaque undergo fissuring by relating their mechanical with their cellular and biochemical properties; and to quantify the distribution of fissures. Results so far indicate that fissures occur predominantly in plaques with lipid pools in one segment of intima, and that the commonest single site of fissuring is that of maximal stress concentration as predicted by computer modelling. The results also suggest that arterial spasm at the immediate site of fissuring is not involved, as more than half the fissures occur at sites where there is no residual medial smooth muscle. Obstructive coronary thrombosis is initiated in most cases by plaque fissure with local haemorrhage which induces intravascular platelet aggregation. Recent observations with novel techniques have provided evidence that platelet aggregation in vivo is initiated by ADP and potentiated by thromboxane A2 and thrombin, with actual contribution of exposed collagen still undetermined. These observations provide an explanation for the limited effectiveness of any simple platelet-inhibiting drug, including Aspirin, by itself whenever arterial, eg. coronary or cerebral thrombosis is initiated by haemorrhages into atheromatous plaques. On the other hand, Aspirin is significantly effective when myocardial infarction follows unstable angina and when strokes follow transient episodes of cerebral ischaemia. This partial effectiveness can be explained through an action of Aspirin on platelets by assuming that, in such cases, their thrombo-embolic aggregation is initiated by haemodynamic effects of atheromatous lesions. Recently we discovered that the uptake of atherogenic low-density lipoprotein is accelerated by noradrenaline at its physiological blood concentrations (Shafi, Cusack & Born, 1989: Proc. Roy. Soc. B., 235, 289). This may help to explain the increased incidence of coronary thrombosis in conditions associated with elevated blood noradrenaline, including cigarette smoking and stress; and it may open new therapeutic approaches.


Platelet Aggregation Unstable Angina Coronary Thrombosis Adenosine Diphosphate Atheromatous Plaque 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Born, G. V. R., and Richardson, P. D., Activation time of blood platelets, J. Membr. Biol., 57:87–90 (1980)PubMedCrossRefGoogle Scholar
  2. Born, G. V. R., Görög, P., and Kratzer, M. A. A., Aggregation of platelets in damaged vessels, Phil. Trans. R. Soc. Lond. B., 294:241–250 (1981).CrossRefGoogle Scholar
  3. Born, G. V. R., Arterial thrombosis and its prevention, in: Proc. VIII World Congress, Cardiology. S. Hayase, S. Murao (eds). Amsterdam: Excerpta Medica 81–91 (1979).Google Scholar
  4. Born, G. V. R., Fluid-mechanical and biochemical interactions in haemostasis, Br. Med. Bull., 33:193–197 (1977).PubMedGoogle Scholar
  5. Born, G. V. R., Platelets in thrombogenesis: mechanism and inhibition of platelet aggregation, Ann. R. Coll. Surg. Engl., 36:200–206 (1965).PubMedGoogle Scholar
  6. Born, G. V. R., and Kratzer, M. A. A., Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man, J. Physiol Lond, 354:419–429 (1984).PubMedGoogle Scholar
  7. Born, G. V. R., The carotid plaque, in: Extracranial Cerebrovascular Disease: Diagnosis and Management, F. Robicsek (ed). New York: Macmillan (in press) (1985).Google Scholar
  8. Cairns, J., Gent, M., Singer, J., Finnie, K., Froggatt, G., Holder, D., Jablonsky, G., Kostuk, W., Melendez, L., Myers, M., Sackett, D., Sealey, B. Q., and Tamer, P., A study of Aspirin (ASA) and sulfinpyrazone (S) in unstable angina, Circulation, 70:suppl 2, Abstract 1659 (1984).Google Scholar
  9. Constantinides, P., Plaque fissures in human coronary thrombosis, J. Atheroscler. Res., 6:1–17 (1966).CrossRefGoogle Scholar
  10. Davies, M. J., and Thomas, T., Thepathological basis and microanatomy of occlusive thrombus formation in human coronary arteries, Phil. Trans. R. Soc. Lond. B., 294:225–229 (1981).CrossRefGoogle Scholar
  11. Davies, M. J., and Thomas, A., Thrombosis and acute coronary-artery lesions in sudden cardiac ischaemic death, New Engl. J. Med., 310:1137–1140 (1984).PubMedCrossRefGoogle Scholar
  12. Didisheim, P., Pavlovsky, M., and Kobayashi, I., Factors that influence or modify platelet function, Ann. N. Y. Acad. Sci., 201:307–315 (1972).PubMedCrossRefGoogle Scholar
  13. Fields, W. S., Lemak, R. F., and Frankowski, R. F., Controlled trials of Aspirin in cerebral ischaemia, Stroke, 8:301–328 (1977).PubMedCrossRefGoogle Scholar
  14. Friedman, M., and Byers, S. O., Induction of thrombi upon preexisting arterial plaques, Amer. J. Path., 46:567–75, (1965).PubMedGoogle Scholar
  15. Hugues, J. C., Agglutination précoce des plaquettes au cours de la formation du clou hémostatique, Thromb. Diathès. haemorrh., 3:177–186 (1959).Google Scholar
  16. Lewis, Jr., H. D., Davies, J. W., Archibald, D. G., Steinke, W. E., Smitherman, T. C., III Doherty, J. E., Schnaper, H. W., LeWinter, M. M., Linares, E., Maurice Pouget, J., Sabharwal, S. C., Chesler, E., and DeMots, H., Protective effects of Aspirin against acute myocardial infarction and death in men with unstable angina, New Engl. J. Med., 309:396–403 (1983).PubMedCrossRefGoogle Scholar
  17. Lusby, R. J., Ferrell, L. D., Ehrenfeld, W. K., Stoney, R. J., and Wylie, E. J., Carotid plaque haemorrhage: its role in production of cerebral ischaemia, Arch. Surg., 117:1479–1488 (1982).PubMedCrossRefGoogle Scholar
  18. Lusby, R. J., Machleder, H. I., Jeans, W., Skidmore, R., Woodcock, J. P., Clifford, P. C., and Baird, R. N., Vessel wall and blood flow dynamics in arterial diseases, Phil. Trans. R. Soc. Lond. B., 294:231–239 (1981).CrossRefGoogle Scholar
  19. May, G. S., Eberlein, K. A., Furberg, C. D., Passamain, E. R., and DeMets, D. S., Secondary prevention after myocardial infarction: a review of long-term trials, Prog. Cardiovas. Dis., 24:331–352 (1982).CrossRefGoogle Scholar
  20. Mustard, J. F., Moore, S., Packham, M. A., Kinlough Rathbone, R. L., Platelets, thrombosis and atherosclerosis, Proc. Biochem. Pharmacol., 13:312–325 (1977).Google Scholar
  21. Mustard, J. F., Murphy E. A., Rowsell, H. C., and Downie, H. G., Factors influencing thrombus formation in vivo, Amer. J. Med., 33:621–647 (1962).Google Scholar
  22. Richardson, P. D., Galletti, P. M., and Born, G. V. R., Regional administration of drugs to control thrombosis in artificial organs, Trans. Am. Soc. Artif. Intern. Organs., 22:22–29 (1976).PubMedGoogle Scholar
  23. Rowntree, L. G., and Shionya, T., Studies in experimental extracorporeal thrombosis. Part I: Methods for the direct observation of extra-corporeal thrombus formation, J. Exp. Med., 46:7–12 (1927).PubMedCrossRefGoogle Scholar
  24. Turitto, V. T., and Baumgartner, H. R., Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells, Microvasc. Res., 5:167–79 (1975).Google Scholar
  25. Wilner, G. D., Nossell, H. L., and LeRoy, E. C., Aggregation of platelets by collagen, J. Clin. Invest., 47:2616–2621 (1968).PubMedCrossRefGoogle Scholar
  26. Zawilska, K. M., Born, G. V. R., and Begent, N. A., Effect of ADP-utilising enzymes on the arterial bleeding time in rats and rabbits, Br. J. Haematol., 50:317–325 (1982).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • G. V. R. Born
    • 1
  1. 1.Pathopharmacology UnitThe William Harvey Research Institute St. Bartholomew’s Hospital Medical CollegeLondonUK

Personalised recommendations